Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • PharmaTutor
    19 March 2010

    NIPER Ahmedabad to introduce PG diploma course for medical devices sector in July, 2010

     The National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, is all set to launch India's first dedicated course in medical devices segment from the new academic year starting from July, 2010. The institute is currently in talks with some of the major educational institutes conducting similar courses in the country for expert opinion and will finalise the curriculum soon, senior officials of the institute said.

  • 19 March 2010
    Bangalore India Bio expects wide biotech industry participation

     Technology Vision Group (TVG) has announced a collaboration with India-based MMActiv, ABLE and the Vision Group on Biotechnology to produce BioPartnering India (BPI) at Bangalore India Bio, India's largest biotechnology event, which is scheduled on June 2-4, 2010. These combined events offer delegates the opportunities for partnering in India.

  • 17 March 2010
    NEWS: Warfarin Genotyping Reduces Hospitalizations

    March 16, 2010 (Atlanta, Georgia) — Genotyping warfarin  patients resulted in a 30% reduction in all-cause hospitalizations and hospitalizations for bleeds/thromboemboli, a new study suggests.

  • 17 March 2010
    Duty of regulatory agencies must be to prevent harm from unsafe drugs, Kim Huynh-Ba.

    The primary duty of the regulatory bodies across the world is to prevent harm from unsafe drugs. In the United States, the law ensures that there shall be a written stability testing programme to assess the stability characteristics of drug products. Stability is the critical quality attribute of a drug product. Further it ensures the capacity of a drug substance, said Kim Huynh-Ba, Technical director of Pharmalytik, Newark in USA.

  • 17 March 2010
    Several drugs to come under regulatory scanner as national pharmacovigilance programme to begin in April

    Two H1N1 drugs - oseltamivir and zanamavir, the controversial sub-fertility drug letrozole, popular non-steroidal anti-inflammatory drug nimesulide, decongestant drug phenylpropanolamine (PPA), antibiotic drug gatifloxacine, chronic constipation drug tegaserod, type-2 diabetes drug pioglitazone and rosiglitazone have been selected for the first phase of national pharmacovigilance programme which will begin in select 40 medical colleges across the country from April this year.

  • 17 March 2010
    GVK Bio opens new clinical pharmacology unit in Ahmedabad

    GVK Biosciences, a contract research organization, has commissioned its new clinical pharmacology unit (CPU) in Ahmedabad. The facility adds 110 beds to the company's existing capacity of 144 beds and will conduct a range of tests on healthy volunteers.

  • 6 March 2010
    FDA Approves New Somatropin Injection Pen for Growth Hormone Disorders

    March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone disorders in adult and pediatric patients. The product, an updated version of the company's NordiFlex pen introduced in 2004, is expected to be available in the second quarter of 2010.

    [adsense:336x280:8701650588]

  • 6 March 2010
    Haffkine Institute to establish BA/BE study centre soon

    The more than 100-year old Haffkine Institute of Mumbai will soon establish a BA/BE study centre which will be useful to the pharma industry in India and abroad in getting a more authentic bioavailability and bioequivalence (BA/BE) study results. The government-controlled Institute has already started the process in this regard and is expected to be completed within a year's time.

  • 6 March 2010
    Himalaya enters chronic respiratory allergy segment with Bresol

    The Himalaya Drug Company has ventured into cough suppressants space with the launch of Bresol, a breathing solution for treating chronic respiratory allergies. Bresol will be an ethically promoted product from the company's Pharma division.

  • 6 March 2010
    Gujarat FDCA appoints 156 staff in one go to avoid backlog in samples testing

    The Gujarat Food and Drug Control Administration (FDCA) has completed a mass recruitment process in the first week of March by giving away appointment letters to 156 candidates in one go, probably the biggest recruitment since the inception of the administration, in a move to hasten the monitoring activities of food and drugs marketed in the state.

Subscribe to Pharma News